Skip to Main Content

Paper Details

Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer.
Br J Cancer
21
2020
PSA, Plasma, Plasma tumour DNA, androgen, bone flare, cancers, mCRPC, metastatic castration-resistant prostate cancer, patients, prostate cancer, prostate-specific antigen, ptDNA, taxanes, tumour
Author NameAffiliation
Alessandro RomanelUniversity of Trento
Alessandro RomanelUniversity of Trento
Francesca DemichelisUniversity of Trento
Francesca DemichelisUniversity of Trento
Gerhardt AttardUniversity College London Cancer Institute
  • 1 - 5

Datasets

Release 1.2